| Size & multiples | |||
| Market Cap | $5.06B | Enterprise Value | $6.89B |
| P/E (TTM) | 65.78× | PEG (trailing) | — |
| P/S | 4.26× | P/FCF | 52.30× |
| EV/EBITDA | 16.23× | EV/EBIT | 23.15× |
| EV/Sales | 5.79× | EV/FCF | 71.13× |
| FCF Yield | 1.91% | Buyback Yield | — |
| Owner Earnings (TTM) | $117.8M | Owner Earnings Yield | 2.33% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.74 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 12.71% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.27 · revenue TTM $1.19B · FCF TTM $96.8M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 87th · EV/EBITDA 59th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 65.8x | 24.4x | 13.0x–39.3x | 87 ↑rich |
| EV/EBITDA | 17.5x | 15.1x | 9.8x–24.4x | 59 ↑rich |
| FCF Yield | 2.9% | -7.8% | -34.7%–1.4% | 80 ↑strong |
| Dividend Yield | 0.0% | 1.1% | 0.2%–2.4% | 10 ↓weak |
| Net Margin | 6.7% | -21.2% | -325.3%–7.2% | 74 ↑strong |
| Operating Margin | 25.6% | -34.5% | -552.0%–8.0% | 94 ↑strong |
| ROE | 15.4% | -36.8% | -92.5%–4.5% | 85 ↑strong |
